vimarsana.com

ப்ரிந்ஸிபல் சுகாதாரம் கண்டுபிடிப்பாளர்கள் குறியீட்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Goldman Sachs Likes These Health Tech Stocks

An ETF to Home In on Innovative Health Care Growth

An exchange traded fund that tracks healthcare and technology themes can help diversify and enhance investment portfolios. In the recent webcast, Investing for tomorrow, today: Exploring the future of health care, Matthew Cohen, Head of ETF Specialist Team, Principal Global Investors, underscored persisting demand for innovation that will keep producing results for investors over the long haul. For example, overarching themes like an aging population, a growing health economy, and the fight against chronic and rare illnesses will continue to fuel demand for innovative healthcare services. About 10,000 people per day will turn 65 through fiscal year 2030. From the fiscal year 2018 through 2022, global healthcare spending is expected to increase at a compound annual growth rate of 5.4%, compared to a 2.1% projected global GDP. Meanwhile, the cost of care for those with chronic conditions today has increased to $1.1 trillion, or 10x more expensive than non-chronic patients. Additio

Investing for Tomorrow, Today: Exploring the Future of Health Care

Investing for Tomorrow, Today: Exploring the Future of Health Care In the upcoming webcast, Investing for tomorrow, today: Exploring the future of health care, Steve Jones, Client Portfolio Manager, Principal Global Systematic Solutions; Jeffrey Schwarte, Portfolio Manager and Head of Systematic Solutions, Principal Global Systematic Solutions; and Matthew Cohen, Head of ETF Specialist Team, Principal Global Investors, will highlight the healthcare and technology investment themes and their place in your portfolios. Specifically, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) can provide a targeted investment strategy designed to capitalize on innovation in the healthcare sector. With its positioning at the cusp of healthcare innovation, a theme being spotlighted by the COVID-19 pandemic, BTEC is proving youthful healthcare investments that can be served. BTEC seeks to tap into the increasing demand for healthcare solutions as demographic trends have driven healt

Health Tech x Remote Work: Principal s BTEC ETF

The coronavirus pandemic altered the healthcare landscape and how and where people work. The BTEC seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index (including growth and value stock) that are small- and medium-capitalization U.S. healthcare companies. Health tech will be integral in getting workers back to their offices safely.

J&J s Vaccine Rollout a Shot in the Arm for These Biotech ETFs

The FDA met Friday to review J&J’s request for emergency use authorization. Approvals occurred shortly after similar requests by Pfizer and Moderna. After J&J submitted its vaccine study data to the Food and Drug Administration earlier this month, the FDA staff said it determined that the clinical trial results and safety data were “consistent with the recommendations set forth in FDA’s guidance Emergency Use Authorization for Vaccines to Prevent COVID-19.” The vaccine’s level of protection varied by region, J&J said, with the shot demonstrating 66% effectiveness overall, 72% in the United States, 66% in Latin America, and 57% in South Africa, where the B.1.351 variant is rapidly spreading. However, the FDA staff documents showed the vaccine was 64% effective in South Africa after about a month. The company said the vaccine prevented 100% of hospitalizations and deaths.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.